Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Lilly

Vaccine Delays in Europe Lead to German Direct Purchase of $486m of Lilly & Regeneron Monoclonal Antibody Products Despite No Formal Approval

As frustration mounts in places such as Germany with what is perceived as a slow and inefficient vaccine rollout, calls […]

Vaccine Delays in Europe Lead to German Direct Purchase of $486m of Lilly & Regeneron Monoclonal Antibody Products Despite No Formal Approval
1 month ago
Share

Lilly Injects $30m into Fund Targeting Healthcare Inequities in America—Untapped Potential

The Unseen Capital Health Fund LP, a newly-formed venture fund created by racially diverse and historically unrepresented business leaders was […]

Lilly Injects $30m into Fund Targeting Healthcare Inequities in America—Untapped Potential
2 months ago
Share

Infectious Diseases Society of America Cautious with Lilly’s Monoclonal Antibody Product for COVID-19—Recommends Against Routine Usage

Although there has been considerable buzz around the recent U.S. Food and Drug Administration (FDA) acceptance of Eli Lilly’s monoclonal […]

Infectious Diseases Society of America Cautious with Lilly’s Monoclonal Antibody Product for COVID-19—Recommends Against Routine Usage
3 months ago
Share

Bamlanivimab: Monoclonal Antibody Treatment Presents Special Difficulties in Administration

The medical and research establishments certainly have given their best during this pandemic. Eli Lilly is no exception, having marshalled […]

Bamlanivimab Monoclonal Antibody Treatment Presents Special Difficulties in Administration
4 months ago
Share

BenevolentAI Established the Connection: Lilly’s Baricitinib Appears Effective Against COVID-19 in European Clinical Trial

Back in late January, a British artificial intelligence (AI) venture known as BenevolentAI was employed to investigate thousands of potential drug […]

BenevolentAI Established the Connection Lilly’s Baricitinib Appears Effective Against COVID-19 in European Clinical Trial
4 months ago
Share

‘Serious Quality Problems’ at Eli Lilly Production Facility Used to Produce POTUS Touted Monoclonal Antibodies

The U.S. Food and Drug Administration (FDA), not the clinical sponsor, paused a recent study based on serious quality control […]

‘Serious Quality Problems’ at Eli Lilly Production Facility Used to Produce POTUS Touted Monoclonal Antibodies
4 months ago
Share

Lilly’s Monoclonal Antibody (Bamlanivimab) Falters in ACTIV-3 but Other Studies Continue

The ACTIV-3 clinical trial is being run by the National Institute of Allergy and Infectious Diseases (NIAID), part of the […]

Lilly’s Monoclonal Antibody (Bamlanivimab) Falters in ACTIV-3 but Other Studies Continue
4 months ago
Share

NIAID ACTIV-3 Study Investigating LY-CoV555 & Remdesivir Placed on Pause: Drug Safety Monitoring Board Move Based on Safety Concern

The ACTIV-3 clinical trial, funded by the National Institute of Allergy and Infectious Diseases (NIAID) and a large group of […]

NIAID ACTIV-3 Study Investigating LY-CoV555 & Remdesivir Placed on Pause: Drug Safety Monitoring Board Move Based on Safety Concern
5 months ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.